Natural Killer Cell: all 56 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- NK Cell Injection for Advanced Solid TumorsNot yet recruitingNCT07784777Phase 1
- A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent GlioblastomaRecruitingNCT07579208Phase 1
- Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")RecruitingNCT07411599Phase 1/2
- Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and GanglioneuroblastomaRecruitingNCT07375563Phase 3
- NK Cell Infusion for Remission Consolidation in AML: A Phase II TrialNot yet recruitingNCT06783478Phase 2
- A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.RecruitingNCT06641648Phase 1
- A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)RecruitingNCT05834244Phase 1
- Quadruple Immunotherapy for NeuroblastomaRecruitingNCT05754684Phase 2
- Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid LeukemiaNot yet recruitingNCT05319249Phase 1/2
- Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer CellsRecruitingNCT04254419Phase 1
- Therapy for Children With Advanced Stage NeuroblastomaCompletedNCT01857934Phase 2Results posted
- Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory NeuroblastomaTerminatedNCT00698009Phase 2Results posted
- Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial CarcinomaActive, not recruitingNCT06318871Early Phase 1
- Camrelizumab in Combination With Apatinib Plus NK Cell for Advanced HCCStatus unknownNCT05171309Phase 2
- NK Cells Treatment for COVID-19CompletedNCT04280224Phase 1
- Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR MutationStatus unknownNCT03662477Early Phase 1
- NK Cells Infusion for Advanced MalignanciesStatus unknownNCT03619954Phase 1
- NK Cell-based Immunotherapy as Maintenance Therapy for Small-Cell Lung Cancer.Status unknownNCT03410368Phase 2
- Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract CancerCompletedNCT03358849Phase 1
- Adoptive Transfer of Haploidentical Natural Killer Cells and IL-2CompletedNCT03346499Phase 1
- Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)Status unknownNCT02961712Phase 1
- Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid TumorsCompletedNCT02857920Phase 1/2
- Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid TumorsCompletedNCT02853903Phase 2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Tongue CancerCompletedNCT02849379Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Recurrent SarcomaCompletedNCT02849366Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Ovarian CancerCompletedNCT02849353Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Cervical CancerCompletedNCT02849340Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal CancerCompletedNCT02849327Phase 1/2
- Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal CancerCompletedNCT02849314Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted LiverCompletedNCT02849015Phase 1/2
- Combination of Cetuximab and NK Immunotherapy for Recurrent Non-small Cell Lung CancerCompletedNCT02845856Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Breast CancerCompletedNCT02844335Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Non-Small Cell Lung CancerCompletedNCT02843815Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Liver CancerCompletedNCT02843802Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney CancerCompletedNCT02843607Phase 1/2
- Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal CancerCompletedNCT02843581Phase 1/2
- Combination of Anti-PD-1 and NK Immunotherapy for Recurrent Solid TumorsCompletedNCT02843204Phase 1/2
- Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast CancerCompletedNCT02843126Phase 1/2
- Combination of Rituximab and NK Immunotherapy for B LymphomaCompletedNCT02843061Phase 1/2
- Combination Trastuzumab With Expanded Natural Killer Cells for Treating HER2-positive Gastric CancerStatus unknownNCT02805829Phase 1/2
- A Clinical Research of NK Cell Infusion Combined With Chemotherapy in the Treatment of Non-small Cell Lung CancerStatus unknownNCT02734524Phase 2
- By Using Adoptive Transfer of Autologous NK Cells to Prevent Recurrence of Hepatocellular Carcinoma After Curative TherapyStatus unknownNCT02725996Phase 2
- Combination of Irreversible Electroporation and NK Immunotherapy for Advanced Pancreatic CancerCompletedNCT02718859Phase 1/2
- Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK CellsActive, not recruitingNCT02573896Phase 1
- Reactivating NK Cells in Treating Refractory Head and Neck CancerStatus unknownNCT02507154Phase 1/2
- Randomised Controlled Phase-2 Trial to Determine the Efficacy of Adoptive Immunotherapy With NK Cells in High-risk AMLTerminatedNCT02229266Phase 2
- Natural Killer Cells in Acute Leukaemia and Myelodysplastic SyndromeStatus unknownNCT02123836Phase 1
- Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal CancerCompletedNCT02118285Phase 1
- NK Cell Infusions With Trastuzumab for Patients With HER2+ Breast and Gastric CancerStatus unknownNCT02030561Phase 1/2
- Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell TransplantationCompletedNCT01853358Phase 1
- Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic LeukemiaCompletedNCT00995137Phase 1
- Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer CellsStatus unknownNCT00799799Phase 1
- Natural Killer Cells and Bortezomib to Treat CancerCompletedNCT00720785Phase 1
- A Pilot Study of Autologous Ex Vivo Activated NK Cell Infusion in the Treatment of Metastatic Nasopharyngeal CarcinomaCompletedNCT00717184Phase 1
- Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell InfusionsCompletedNCT00660166Phase 1
- Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationCompletedNCT00383994Phase 1